1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | Licensing Program Analysts (LPAs) Joe Katrdzhyan and Nune Margaryan conducted an unannounced case management visit to this facility. Upon arriving at the facility, LPAs met with Facility Manager / Lupe Harvey who assisted with the visit. LPAs explained the purpose of this visit is to conduct a health and safety check for the residents in care.
- At approximately 11:45AM, LPAs toured the facility and tested the auditory chimes located on the exit doors of the facility (both floors) and observed the auditory chimes were operable.
- At approximately 12:05PM, LPA Katrdzhyan toured the kitchen and observed an ample supply of nonperishable foods for a minimum of one week and perishable foods for a minimum of two days.
- At approximately 12:15PM, LPA Katrdzhyan reviewed the list of medications being administered to Resident #1 (R1) and discovered that the medications listed below were missing from the facility and not being administered per physician's orders;
• Fluoxetine 20 MG Capsule • Neurontin 600 MG Tablet • Tramadol 50 MG Tablet • Macrobid 100 MG Capsule • Divalproex 125 MG Tablet • Depakote 250 MG Tablet • Nitrostat 0.4 MG Sublingual Tablet
• Fluoxetine 40 MG Capsule
- Also, MULTI Vitamins & Minerals is being administered to R1 every morning without a written order / prescription from a physician.
The medication errors listed above present an immediate health and safety concern for R1.
The following deficiencies were observed to be in violation of California code of Regulations, Title 22, Division 6 (refer to 809D)
An exit interview was conducted and a copy of this report was provided to the Facility Manager along with the Appeals Rights. |